- Home
- SOFI vs BNTX Comparison
SOFI vs BNTX Comparison
Compare SOFI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOFI | BNTX |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 24.2B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SOFI | BNTX |
|---|---|---|
| Price | $18.55 | $91.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 13 |
| Target Price | $24.43 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 54.9M | 792.8K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $619,353,000.00 | N/A |
| Revenue This Year | $32.54 | N/A |
| Revenue Next Year | $21.82 | $3.37 |
| P/E Ratio | $151.25 | ★ N/A |
| Revenue Growth | ★ 23.10 | N/A |
| 52 Week Low | $13.23 | $79.81 |
| 52 Week High | $32.73 | $124.00 |
Technical Indicators
Market Signals| Indicator | SOFI | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 44.09 |
| Support Level | $16.79 | $90.67 |
| Resistance Level | $19.81 | $95.14 |
| Average True Range (ATR) | 0.79 | 2.69 |
| MACD | 0.36 | 0.35 |
| Stochastic Oscillator | 92.25 | 38.85 |
Price Performance
Historical ComparisonAbout SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.